Anhui Sunhere Pharmaceutical Excipients Co Ltd

Anhui Sunhere Pharmaceutical Excipients Co Ltd maintains a strong liquidity position with a current ratio of 4.14, indicating the company can easily cover its short-term liabilities with its short-term assets. However, the company has a negative net cash position after subtracting total debt, which introduces a medium liquidity risk. The debt-to-equity ratio of 0.32 suggests a relatively conservative capital structure, with a moderate reliance on debt financing. The company's profitability is reflected in a return on equity (ROE) of 17.54% and a return on assets (ROA) of 10.31%, both of which are strong indicators of efficient use of equity and assets to generate profit. These metrics suggest the company is performing well compared to the industry's preferred metrics, though direct comparisons to cohort medians are not available in the current dataset. Geographically and segment-wise, the company's exposure is not explicitly detailed in the available data. However, the company operates primarily in the pharmaceutical excipients market, which is a critical component of the broader pharmaceutical industry. The lack of detailed segment or geographic breakdown limits the ability to assess revenue concentration or diversification. The company's growth trajectory is not explicitly outlined in the available data, but the operating cash flow of 191.99 million CNY and free cash flow of 114.42 million CNY suggest a healthy cash-generating business. Analysts have provided a consistent price target of 15.60 CNY, indicating a stable outlook for the company's stock. The company faces a medium liquidity risk and a low dilution risk. The risk assessment indicates that the company is not currently under significant pressure to issue new shares, and there are no immediate signs of dilution. The capital structure remains stable, and the company has not made any recent adjustments that would significantly alter its valuation. There are no recent filings or transcripts available in the dataset that would indicate significant changes in the company's operations or strategy. The company appears to be maintaining a steady course, with no major events reported in the latest available data.